Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke
Keun-Sik HONG; Sang-Bae KO; Kyung-Ho YU; Cheolkyu JUNG; Sukh-Que PARK; Byung-Moon KIM; Chul-Hoon CHANG; Hee-Joon BAE; Ji-Hoe HEO; Chang-Wan OH; Byung-Chul LEE; Bum-Tae KIM; Bum-Soo KIM; Chin-Sang CHUNG; Byung-Woo YOON; Joung-Ho RHA.
Journal of the Korean Neurological Association
; : 297-311, 2016.
Artículo
en Ko
| WPRIM | ID: wpr-182777
Patients with severe stroke due to acute large cerebral artery occlusion are likely to be severely disabled or die if reperfusion is not achieved in a timely manner. Intravenous tissue plasminogen activator (IV-TPA) administered within 4.5 hours after stroke onset was previously the only proven therapy, but IV-TPA alone does not sufficiently improve the outcome of patients with acute large artery occlusion. With the introduction of the advanced endovascular therapy that enables faster and more successful recanalization, recent randomized trials consecutively and consistently demonstrated the benefit of adding endovascular recanalization therapy (ERT) to IV-TPA. Accordingly, to update the recommendations, we assembled members of a writing committee appointed by the Korean Stroke Society, the Korean Society of Interventional Neuroradiology, and the Society of Korean Endovascular Neurosurgeons. The writing committee revised recommendations based on a review of the accumulated evidence, and a formal consensus was achieved by convening a panel of 34 experts from the participating academic societies. The current guideline provides evidence-based recommendations for ERT in patients with acute large cerebral artery occlusion regarding patient selection, treatment modalities, neuroimaging evaluation, and system organization.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados